<DOC>
	<DOCNO>NCT01711762</DOCNO>
	<brief_summary>This open-label , non-randomized study assess absorption , metabolism , excretion radioactive-labeled [ 14C ] -GDC-0973 healthy male volunteer . Volunteers receive single dose [ 14C ] -GDC-0973 .</brief_summary>
	<brief_title>A Pharmacokinetics Study Radioactive-Labeled GDC-0973 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Body mass index ( BMI ) 18.5 29.9 kg/m2 , inclusive No clinically significant finding medical history , 12lead ECG , vital sign laboratory evaluation Negative test select drug abuse No infection hepatitis B , hepatitis C , human immunodeficiency virus ( HIV ) Sterile agree use adequate contraception method Historically able produce minimum 1 bowel movement per day Significant history clinical manifestation significant metabolic , allergic , dermatological , hepatic , renal , hematological , pulmonary , cardiovascular , gastrointestinal , neurological , psychiatric disorder History significant hypersensitivity , intolerance , allergy drug compound , food , substance unless approve Investigator History stomach intestinal surgery resection ( include cholecystectomy ) would potentially alter absorption and/or excretion orally administer drug except appendectomy and/or hernia repair allow History Gilbert 's Syndrome History diabetes mellitus and/or elevate fast glucose baseline History presence abnormal ECG History alcoholism drug addiction within 1 year prior Checkin Participation one radiolabeled investigational study drug trial within 12 month prior Checkin Exposure significant radiation within 12 month prior Checkin study drug occur within 5 halflives 30 day , whichever longer , prior Checkin Use tobaccocontaining nicotinecontaining product within 6 month prior Checkin Participation investigational study drug biologic agent trial receipt investigational study drug occur within 5 halflives 30 day , whichever longer , prior Checkin Use prescription medications/products within 14 day prior Checkin</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>